Urticária — Urticária tem cura? — Qual o tratamento?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Urticária — Urticária tem cura? — Qual o tratamento?

Clinical Summary and Overview

When symptoms or doubts arise involving UrticariaDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "Urticária — Urticária tem cura? — Qual o tratamento?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Urticária — Urticária tem cura? — Qual o tratamento?

Compreendendo a Urticária: Classificação, Causas e Tratamento

A urticária é uma condição dermatológica bastante comum caracterizada pelo surgimento de lesões avermelhadas na pele, conhecidas como pápulas, que vêm acompanhadas de intenso prurido (coceira) e, muitas vezes, angioedema (inchaço em camadas mais profundas da pele). Para o correto entendimento e manejo da doença, a medicina divide a urticária em duas grandes classificações temporais e clínicas: a urticária aguda e a urticária crônica.

A urticária aguda é aquela cujos episódios duram até seis semanas. Entre as causas mais frequentes para esse quadro de curto prazo estão os processos infecciosos, as intoxicações e as reações adversas a medicamentos. Quando os sintomas persistem por um período superior a seis semanas, o quadro passa a ser diagnosticado como urticária crônica, exigindo uma investigação médica mais aprofundada.

Classificação e Investigação da Urticária Crônica

A urticária crônica é subdividida clinicamente em diferentes tipos, sendo fundamental a avaliação com um médico especialista em Alergia e Imunologia para o diagnóstico preciso. As principais origens e características compreendem:

  • Urticária crônica espontânea ou idiopática: Representa a grande maioria dos casos. Nessa situação, mesmo após uma investigação detalhada, não se identifica uma causa externa ou doença subjacente específica que desencadeie as crises.
  • Urticária crônica com causa secundária: Embora menos frequente — correspondendo a cerca de 40% dos casos —, pode estar associada a doenças reumáticas, disfunções da tireoide, infecções ocultas ou, mais raramente, a condições hematológicas e doenças linfoproliferativas.

Abordagem Terapêutica e Controle dos Sintomas

A dúvida sobre a possibilidade de controle da condição é muito comum entre os pacientes. Embora muitos quadros possam perdurar, a urticária dispõe de tratamentos eficazes baseados em protocolos médicos atualizados. O manejo inicial geralmente envolve o uso de anti-histamínicos e medicações de controle para suprimir os sintomas e melhorar a qualidade de vida do paciente.

Para os casos de urticária crônica espontânea que se mostram refratários ou irresponíveis ao tratamento tradicional com anti-histamínicos, a medicina moderna conta com terapias avançadas. Entre elas, destaca-se o uso de anticorpos monoclonais, como o omalizumabe, uma medicação específica injetável que pode ser indicada pelo especialista para pacientes que atendem aos critérios clínicos e à faixa etária recomendada.

Nota importante: Este conteúdo possui caráter exclusivamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e o acompanhamento individualizado com um médico especialista em Alergia e Imunologia.

Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema

In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management

Mast Cell Activation, Histamine, and the Bradykinin Pathway

Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.

Therapeutic Escalation without Overuse of Corticosteroids

Identifying aggravating cofactors—especially the use of nonsteroidal anti-inflammatory drugs (NSAIDs), acute stress, and physical stimuli—is part of the specialized consultation. Through the allergy test well-indicated and requiring continuous monitoring aimed at stabilizing mast cells and, in patients with atopic respiratory comorbidities, at allergy vaccineComplete control of symptoms is achieved while preserving overall health.

Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication

Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. For peaceful skin, free from constant itching and sleep-depriving flare-ups.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Urticaria This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: